71 results
424B3
BXRXQ
Baudax Bio, Inc.
22 Nov 23
Prospectus supplement
4:58pm
requires the input of subjective assumptions, including the expected life of the option and expected stock price volatility. The Company uses the Black … September 30, 2023 was $0.24. Under the TeraImmune 2019 Plan, the fair value of the options was estimated on the date of grant using a Black-Scholes
PRER14A
BXRXQ
Baudax Bio, Inc.
25 Aug 23
Preliminary revised proxy
4:01pm
PERCENTAGE
OF COMMON
STOCK
PERCENTAGE
OF SERIES C
PREFERRED
STOCK
5% or Greater Shareholders
Entities affiliated with Black Horse Capital LP
Named … beneficial ownership by the Black Horse Entities (as defined below), the number of shares beneficially owned represents (i) 40,000 shares held by Black Horse
DEFA14A
BXRXQ
Baudax Bio, Inc.
21 Aug 23
Additional proxy soliciting materials
8:05am
the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion … Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant
8-K
EX-4.2
6nh qtxav0geg4rmon8
21 Aug 23
Entry into a Material Definitive Agreement
8:00am
424B5
uc5rl6uc2iu
18 Aug 23
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
llms 46au6mxvr
28 Jun 23
Other Events
4:31pm
8-K
EX-99.1
v79wdo2jcdo1yt7jka9i
10 May 23
Regulation FD Disclosure
8:01am
424B3
6597635 yz26hg1yab
28 Apr 23
Prospectus supplement
4:02pm
8-K
EX-99.2
y7gly1n4
25 Apr 23
Baudax Bio Announces Positive Top-Line Final Results
9:21am
8-K
EX-4.1
vdb j93xj8p
31 Mar 23
Entry into a Material Definitive Agreement
4:50pm